Inhibition of PLK1 by capped‐dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis
暂无分享，去创建一个
J. Slotta-Huspenina | T. Haferlach | I. Waizenegger | K. Götze | F. Bassermann | W. Kern | C. Peschel | S. Jilg | Ritu Mishra | P. Jost | B. Schmidt | U. Höckendorf | P. Prodinger | C. Müller-Thomas | F. Bellos | D. Hempel | V. Dill | Alexander Höllein | Johanna Kauschinger | Richard T. Hauch | L. Buschhorn | T. Odinius | Michele C Kyncl | Richard T Hauch | Ulrike Höckendorf